Fundraising Fox

Biotech Series B Investors & VC Firms

900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.

MIG Capital AG
MunichSeed–Growth$1.1M – $10.8M
23 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Samsara BioCapital
Palo AltoSeed–Late Stage
5 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
Monograph Capital Partners
LondonSeed–Series B
20 people
Forepont Capital Partners
New YorkPre-Seed–Late Stage
24 people
First Momentum
KarlsruhePre-Seed–Series B$216K – $1.1M
11 people
Osage University Partners
Pre-Seed–Late Stage$1M – $20M
21 people
Rising Tide
PacificaPre-Seed–Series B
5 people
4BIO Capital
LondonPre-Seed–Series B
27 people
Forbion
NaardenPre-Seed–Late Stage
24 people
Hadean Ventures
OsloSeed–Growth
21 people
Two Sigma Ventures
New YorkSeed–Series B$2M – $15M
17 people
Lauder Partners
Los AltosSeries B
1 person
Northstar Ventures
Newcastle upon TynePre-Seed–Late Stage$38.1K – $1.3M
19 people
Sunstone Capital
FrederiksbergPre-Seed–Series B
13 people
Taiwan Global Angels
BerkeleyPre-Seed–Growth$300K – $3M
19 people
TVM Capital
MunichSeed–Late Stage$1.1M – $16.2M
22 people
Xiang He Capital
BeijingSeed–Growth
Inkef
AmsterdamSeed–Growth
14 people
Neotribe Ventures
Menlo ParkPre-Seed–Growth$250K – $2M
3 people
Oncology Ventures
New YorkSeed–Series B
18 people
EIT Digital Accelerator
EspooSeries A–Growth$5M – $25M
11 people
Starquest Capital
ParisSeed–Growth$530K – $21.2M
14 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.